Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 3 | Cell Communication and Signaling

Fig. 3

From: Oncogenic potential of SARS-CoV-2—targeting hallmarks of cancer pathways

Fig. 3

The impact of SARS-CoV-2 on tumor-related inflammatory markers and mechanisms of immune evasion is depicted in the figure, illustrating how viral proteins interact with critical molecular targets within inflammatory and immune pathways. TNF-α, Tumor Necrosis Factor-Alpha; IL1, Interleukin 1; PDL1, Programmed Death-Ligand 1; COX 2, Cyclooxygenase 2; ORF 8, Open Reading Frame 8; p38, p38 Mitogen-Activated Protein Kinase; IL1-β, Interleukin 1 Beta; JAK/STAT, Janus Kinase/Signal Transducer and Activator of Transcription; CHK1, Checkpoint Kinase 1; NFκB, Nuclear Factor Kappa B. This image was created using BioRender software

Back to article page

Cell Communication and Signaling

ISSN: 1478-811X